Edition:
United Kingdom

Mersana Therapeutics Inc (MRSN.OQ)

MRSN.OQ on NASDAQ Stock Exchange Global Select Market

16.90USD
23 Feb 2018
Change (% chg)

$0.83 (+5.16%)
Prev Close
$16.07
Open
$16.17
Day's High
$16.95
Day's Low
$15.98
Volume
21,305
Avg. Vol
21,512
52-wk High
$21.01
52-wk Low
$12.65

Select another date:

Tue, Dec 12 2017

BRIEF-Mersana Announces First Patient Dosed With XMT-1536 In Phase 1 Study In Patients With NaPi2b-Expressing Tumors

* MERSANA ANNOUNCES FIRST PATIENT DOSED WITH XMT-1536 IN PHASE 1 STUDY IN PATIENTS WITH NAPI2B-EXPRESSING TUMORS Source text for Eikon: Further company coverage:

BRIEF-Mersana announces third quarter loss of $0.35 per share

* Mersana announces third quarter 2017 financial results and provides business updates

BRIEF-Mersana announces FDA clearance of IND application for XMT-1536

* Mersana announces FDA clearance of IND application for XMT-1536, a first-in-class antibody drug conjugate targeting NaPi2b

BRIEF-Mersana Therapeutics increases size of board and appoints Lawrence Alleva as class III director‍​

* Mersana Therapeutics Inc - Increased size of the board from six to seven directors and appointed Lawrence M. Alleva to serve as a class III director‍​ Source text: (http://bit.ly/2j4r2t3) Further company coverage:

Select another date: